• Have a question?
    Open from 8am to 7pm Monday to Friday    Call customer services
    0345 54 32 600


| Print

Medpace Holdings (MEDP)

Common Shares
Sell: $560.00|Buy: $596.00|Change: 49.87 (9.12%)

Not yet a customer?

Low cost dealing from £1.50

Choose from our range of SIPP, ISA and Dealing accounts

Find out more

This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPP

Company profile

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services,including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Address

5375 Medpace Way
Cincinnati
OH
USA
45227

Telephone

+1 513 579-9911

Website

https://www.medpace.com

Sector 

Healthcare

Forecast key dates

NameKey Date
Medpace Holdings Inc Third Quarter Earnings Conference Call for 20262026-10-23T09:00:00
Medpace Holdings Inc Third Quarter Earnings Results for 20262026-10-22T00:00:00
Medpace Holdings Inc Second Quarter Earnings Conference Call for 20262026-07-22T09:00:00
Medpace Holdings Inc Second Quarter Earnings Results for 20262026-07-21T00:00:00
Medpace Holdings Inc Annual General Meeting for 20262026-05-15T09:00:00
Medpace Holdings Inc First Quarter Earnings Conference Call for 20262026-04-22T09:00:00
Medpace Holdings Inc First Quarter Earnings Results for 20262026-04-21T00:00:00
Medpace Holdings Inc Fourth Quarter Earnings Conference Call for 20252026-02-11T09:00:00
Medpace Holdings Inc Annual Report for 20252026-02-11T00:00:00
Medpace Holdings Inc Fourth Quarter Earnings Results for 20252026-02-10T00:00:00
Medpace Holdings Inc Third Quarter Earnings Conference Call for 20252025-10-23T09:00:00
Medpace Holdings Inc Third Quarter Earnings Results for 20252025-10-22T00:00:00

Previous key dates

NameKey Date
Medpace Holdings Inc Third Quarter Earnings Conference Call for 20252025-10-23T09:00:00
Medpace Holdings Inc Third Quarter Earnings Results for 20252025-10-22T00:00:00
Medpace Holdings Inc Second Quarter Earnings Conference Call for 20252025-07-22T09:00:00
Medpace Holdings Inc Second Quarter Earnings Results for 20252025-07-21T00:00:00
Medpace Holdings Inc Annual General Meeting for 20252025-05-16T09:00:00
Medpace Holdings Inc First Quarter Earnings Conference Call for 20252025-04-22T09:00:00
Medpace Holdings Inc First Quarter Earnings Results for 20252025-04-21T00:00:00
Medpace Holdings Inc Fourth Quarter Earnings Conference Call for 20242025-02-11T09:00:00
Medpace Holdings Inc Annual Report for 20242025-02-11T00:00:00
Medpace Holdings Inc Fourth Quarter Earnings Results for 20242025-02-10T00:00:00
Medpace Holdings Inc Third Quarter Earnings Conference Call for 20242024-10-22T09:00:00
Medpace Holdings Inc Third Quarter Earnings Results for 20242024-10-21T00:00:00

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2025 AJ Bell. All rights reserved.